Literature DB >> 5533332

Oral or nasogastric maintenance therapy for diarrhoea of unknown aetiology resembling cholera.

D R Nalin, R A Cash.   

Abstract

Entities:  

Keywords:  Asia; Clinical Research; Comparative Studies; Developing Countries; Diarrhea; Diseases; Electrolyte Balance; Fluid Balance; Glucose Metabolism Effects; India; Oral Rehydration; Pakistan; Research Methodology; Southern Asia; Studies; Treatment

Mesh：

Substances：

Year:  1970        PMID： 5533332     DOI： 10.1016/0035-9203(70)90020-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  7 in total

1.  Cholera and severe toxigenic diarrhoeas.

Authors:  D R Nalin
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

2.  Management of gastroenteritis at home.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

3.  A comparison of oral replacement solutions containing sodium in concentrations of 120 m mols/L and 60 m mols/L in paediatric diarrhoea.

Authors:  M R Islam; P K Bardhan; M M Rhaman
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

4.  Effects of intraluminal glucose on intestinal secretion induced by heat stable and heat labile Escherichia coli enterotoxin, cholera toxin and theophylline.

Authors:  D L Hamilton; M R Johnson; W E Roe; N O Nielsen
Journal:  Can J Comp Med       Date:  1978-01

5.  Magic bullet: the history of oral rehydration therapy.

Authors:  J N Ruxin
Journal:  Med Hist       Date:  1994-10       Impact factor: 1.419

Review 6.  Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT).

Authors:  David Nalin
Journal:  Trop Med Infect Dis       Date:  2021-03-12

Review 7.  The History of Intravenous and Oral Rehydration and Maintenance Therapy of Cholera and Non-Cholera Dehydrating Diarrheas: A Deconstruction of Translational Medicine: From Bench to Bedside?

Authors:  David R Nalin
Journal:  Trop Med Infect Dis       Date:  2022-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.